Prevalence of Weight Loss Product Use 5.5 Percent in Teens

2024-01-10
临床结果
WEDNESDAY, Jan. 10, 2024 -- Overall, 5.5 percent of adolescents use weight-loss products, with higher use among girls, according to a systematic review and meta-analysis published online Jan. 10 in JAMA Network Open.
Natasha Yvonne Hall, Pharm.B., from the School of Health and Social Development at Deakin University in Melbourne, Australia, and colleagues examined the global prevalence of nonprescription weight-loss product use in children and adolescents in a meta-analysis of 90 articles with 604,552 unique participants (56 percent of studies from North America).
The researchers found that the reported prevalence of nonprescription weight-loss product use was 5.5 percent in adolescents overall. Prevalence was 2.0, 4.4, 6.2, and 8.9 percent in the past week, past month, past year, and lifetime, respectively, when identifying use of weight-loss products in the general population. Girls had higher use of weight-loss products than boys.
"Prevalence of weight-loss product use was higher in North America compared with Asia and Europe and was higher in Asia compared with Europe," the authors write. "Given the individual and public health issues associated with adolescent use of nonprescription weight-loss products, interventions are urgently required to prevent and regulate use of weight-loss products in this population."
Abstract/Full Text
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。